✦ LIBER ✦

Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma

✍ Scribed by Sinha, Rajni; Shenoy, Pareen J.; King, Nassoma; Lechowicz, Mary Jo; Bumpers, Kevin; Hutcherson, Donald; Arellano, Martha; Langston, Amelia; Kaufman, Jonathan; Heffner, Leonard T.; Waller, Edmund K.; Nooka, Ajay; Flowers, Christopher R.; Lonial, Sagar

Book ID: 121408481
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 401 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.05.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective salvage therapy for high-risk

Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide

✍ Lee, Yun-Gyoo; Kwon, Ji-hyun; Kim, Inho; Yoon, Sung Soo; Lee, Jong-Seok; Park, S 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Rituximab, Dexamethasone, Cytarabine, an

Rituximab, Dexamethasone, Cytarabine, and Oxaliplatin (R-DHAX) Is an Effective and Safe Salvage Regimen in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

✍ Julie Lignon; David Sibon; Isabelle Madelaine; Pauline Brice; Patricia Franchi; 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 144 KB

High dose salvage therapy with dose inte

High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma

✍ Vijay, Archana; Duan, Qiuli; Henning, Jan-Willem; Duggan, Peter; Daly, Andrew; S 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 246 KB

An effective salvage treatment using ifo

An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma

✍ Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayash 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 234 KB

Cladribine combined with rituximab (R-2-

Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma

✍ Hirokazu Nagai; Michinori Ogura; Shigeru Kusumoto; Naoto Takahashi; Motoko Yamag 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Erratum to: An effective salvage treatme

Erratum to: An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma

✍ Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayash 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 86 KB